Your browser doesn't support javascript.
loading
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed.
Meemanage, Madusha; Spender, Lindsay C; Collinson, Diane; Iannetta, Joanna; Challapalli, Pranavi; Turbitt, Julie; Clark, Caroline; Baxter, Mark; Murray, Graeme; Walsh, Shaun; Miedzybrodzka, Zofia; Petty, Russell D.
Afiliação
  • Meemanage M; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK.
  • Spender LC; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK.
  • Collinson D; Medical Genetics, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
  • Iannetta J; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK.
  • Challapalli P; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK.
  • Turbitt J; Medical Genetics, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
  • Clark C; Medical Genetics, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
  • Baxter M; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK.
  • Murray G; Pathology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
  • Walsh S; Department of Pathology, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
  • Miedzybrodzka Z; Medical Genetics, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, AB25 2ZD, UK.
  • Petty RD; Medical Oncology Group (Level 7, Corridor C), Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, James Arnott Drive, Dundee, DD1 9SY, UK. r.petty@dundee.ac.uk.
Cancer Chemother Pharmacol ; 87(3): 361-377, 2021 03.
Article em En | MEDLINE | ID: mdl-33169187
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article